• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于测定镓标记的EuK-Sub-kf-(3-碘-y-)-DOTAGA化学纯度和放射化学纯度的高效液相色谱法验证

Validation of HPLC method for the determination of chemical andradiochemical purity of a Ga-labelled EuK-Sub-kf-(3-iodo-y-) DOTAGA.

作者信息

UĞur Ayşe, ElÇİ Şükrü Gökhan, YÜksel Doğangün

机构信息

Department of Nuclear Medicine, Pamukkale University, Education and Research Hospital, Denizli Turkey.

Department of Biomedical Engineering, Faculty of Technology, Pamukkale University, Denizli Turkey.

出版信息

Turk J Chem. 2021 Feb 17;45(1):26-34. doi: 10.3906/kim-2003-19. eCollection 2021.

DOI:10.3906/kim-2003-19
PMID:33679149
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7925295/
Abstract

The prostate-specific membrane antigen (PSMA) represents an ideal biomarker for molecular imaging. Various PSMA-targeted radioligands are available for prostate cancer imaging. In this study, labeling of PSMA I&T with Ga, as well as validation of the radiochemical purity of the synthesis product by reverse phase radio high-performance liquid chromatography (HPLC) method are intended. Since the standard procedure for the quality control (QC) was not available, definition of chemical and radiochemical purity of Ga-PSMA I&T was carried out according to the Q2 (R1) ICH guideline. The standard QC tests were analyzed with Scintomics 8100 radio-HPLC system equipped with a radioactivity detector. The method was evaluated in terms of linearity, precision and accuracy, LOQ, robustness parameters, and specificity. To assess the radiochemical and chemical purity of Ga-PSMA I&T, the developed method was validated to apply safely to patients. An excellent linearity was found between 1μg/mL and 30 μg/mL, with a limit of detection and limit of quantitation of 0.286 μg/mL and 0.866 μg/mL, respectively for Ga-PSMA I&T. The recovery was 96.8 ± 3.8%. The quality control of the final product was performed many times with validated radio-HPLC method and was found to comply with ICH requirements, thus demonstrating the accuracy and robustness of the method for routine clinical practice.

摘要

前列腺特异性膜抗原(PSMA)是分子成像的理想生物标志物。多种靶向PSMA的放射性配体可用于前列腺癌成像。在本研究中,旨在用镓标记PSMA I&T,并通过反相放射性高效液相色谱(HPLC)法验证合成产物的放射化学纯度。由于尚无质量控制(QC)的标准程序,因此根据ICH Q2(R1)指南对Ga-PSMA I&T的化学和放射化学纯度进行了定义。使用配备放射性检测器的Scintomics 8100放射性HPLC系统分析标准QC测试。从线性、精密度、准确度、定量限、稳健性参数和特异性方面对该方法进行了评估。为评估Ga-PSMA I&T的放射化学和化学纯度,对所开发的方法进行了验证,以安全应用于患者。对于Ga-PSMA I&T,在1μg/mL至30μg/mL之间发现了出色的线性,检测限和定量限分别为0.286μg/mL和0.866μg/mL。回收率为96.8±3.8%。使用经过验证的放射性HPLC方法对最终产品进行了多次质量控制,发现其符合ICH要求,从而证明了该方法在常规临床实践中的准确性和稳健性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c7fa/7925295/ecd4f6523bcf/turkjchem-45-26-fig004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c7fa/7925295/c81879eca6f7/turkjchem-45-26-fig001a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c7fa/7925295/5c9b74f48383/turkjchem-45-26-fig002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c7fa/7925295/5b1dc95abd29/turkjchem-45-26-fig003a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c7fa/7925295/ecd4f6523bcf/turkjchem-45-26-fig004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c7fa/7925295/c81879eca6f7/turkjchem-45-26-fig001a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c7fa/7925295/5c9b74f48383/turkjchem-45-26-fig002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c7fa/7925295/5b1dc95abd29/turkjchem-45-26-fig003a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c7fa/7925295/ecd4f6523bcf/turkjchem-45-26-fig004.jpg

相似文献

1
Validation of HPLC method for the determination of chemical andradiochemical purity of a Ga-labelled EuK-Sub-kf-(3-iodo-y-) DOTAGA.用于测定镓标记的EuK-Sub-kf-(3-碘-y-)-DOTAGA化学纯度和放射化学纯度的高效液相色谱法验证
Turk J Chem. 2021 Feb 17;45(1):26-34. doi: 10.3906/kim-2003-19. eCollection 2021.
2
Development and Validation of a High-Pressure Liquid Chromatography Method for the Determination of Chemical Purity and Radiochemical Purity of a [Ga]-Labeled Glu-Urea-Lys(Ahx)-HBED-CC (Positron Emission Tomography) Tracer.一种用于测定[镓]标记的Glu-Urea-Lys(Ahx)-HBED-CC(正电子发射断层扫描)示踪剂化学纯度和放射化学纯度的高压液相色谱法的开发与验证
ACS Omega. 2017 Oct 31;2(10):7120-7126. doi: 10.1021/acsomega.7b00677. Epub 2017 Oct 25.
3
Development and Validation of an Analytical HPLC Method to Assess Chemical and Radiochemical Purity of [Ga]Ga-NODAGA-Exendin-4 Produced by a Fully Automated Method.开发并验证一种分析型 HPLC 方法,用于评估全自动方法制备的 [Ga]Ga-NODAGA-Exendin-4 的化学纯度和放射化学纯度。
Molecules. 2022 Jan 15;27(2):543. doi: 10.3390/molecules27020543.
4
Development and Validation of a GMP-Compliant High-Pressure Liquid Chromatography Method for the Determination of the Chemical and Radiochemical Purity of [F]PSMA-1007, a PET Tracer for the Imaging of Prostate Cancer.一种用于测定[F]PSMA - 1007(一种用于前列腺癌成像的正电子发射断层显像剂)化学纯度和放射化学纯度的符合药品生产质量管理规范的高效液相色谱法的开发与验证
Pharmaceuticals (Basel). 2021 Feb 25;14(3):188. doi: 10.3390/ph14030188.
5
A Specific HPLC Method to Determine Residual HEPES in [Ga]Ga-Radiopharmaceuticals: Development and Validation.一种用于测定 [Ga]Ga 放射性药物中残留 HEPES 的特定 HPLC 方法:开发与验证。
Molecules. 2022 Jul 13;27(14):4477. doi: 10.3390/molecules27144477.
6
Development and Validation of Analytical Methods for Radiochemical Purity of Lu-PSMA-1.镥-PSMA-1放射化学纯度分析方法的开发与验证
Pharmaceuticals (Basel). 2022 Apr 24;15(5):522. doi: 10.3390/ph15050522.
7
Physiological Animal Imaging with Ga-Citrate.镓柠檬酸盐的生理学动物成像。
Curr Radiopharm. 2021;14(1):51-56. doi: 10.2174/1874471013666200421114031.
8
Development and validation of a UV-Radio-HPLC method to assess chemical and radiochemical purity of [Ga] Ga-PSMA-11.建立并验证一种用于评估[Ga]Ga-PSMA-11 的化学和放射化学纯度的 UV-Radio-HPLC 方法。
Appl Radiat Isot. 2022 Dec;190:110487. doi: 10.1016/j.apradiso.2022.110487. Epub 2022 Sep 29.
9
Improved quality control of [Lu]Lu-PSMA I&T.提高[镥]镥-PSMA I&T的质量控制。
EJNMMI Radiopharm Chem. 2023 Mar 27;8(1):7. doi: 10.1186/s41181-023-00191-6.
10
More advantages in detecting bone and soft tissue metastases from prostate cancer using F-PSMA PET/CT.使用F-PSMA PET/CT检测前列腺癌骨和软组织转移方面有更多优势。
Hell J Nucl Med. 2019 Jan-Apr;22(1):6-9. doi: 10.1967/s002449910952. Epub 2019 Mar 7.

引用本文的文献

1
"One Method to Label Them All": A Single Fully Automated Protocol for GMP-Compliant Ga Radiolabeling of PSMA-11, Transposable to PSMA-I&T and PSMA-617.“一法通用”:一种符合 GMP 标准的 PSMA-11 全自动伽马放射性标记方法,可推广至 PSMA-I&T 和 PSMA-617。
Curr Radiopharm. 2024;17(3):285-301. doi: 10.2174/0118744710293461240219111852.
2
Quality control of [Lu]Lu-PSMA preparations using HPLC: effect of sample composition and ligand on recovery.使用高效液相色谱法对[镥]镥-PSMA制剂进行质量控制:样品组成和配体对回收率的影响。
EJNMMI Radiopharm Chem. 2022 Sep 27;7(1):24. doi: 10.1186/s41181-022-00178-9.
3
Development and Validation of Analytical Methods for Radiochemical Purity of Lu-PSMA-1.

本文引用的文献

1
PSMA Theranostics: Current Status and Future Directions.前列腺特异性膜抗原诊疗学:现状与未来方向
Mol Imaging. 2018 Jan-Dec;17:1536012118776068. doi: 10.1177/1536012118776068.
2
Development and Validation of a High-Pressure Liquid Chromatography Method for the Determination of Chemical Purity and Radiochemical Purity of a [Ga]-Labeled Glu-Urea-Lys(Ahx)-HBED-CC (Positron Emission Tomography) Tracer.一种用于测定[镓]标记的Glu-Urea-Lys(Ahx)-HBED-CC(正电子发射断层扫描)示踪剂化学纯度和放射化学纯度的高压液相色谱法的开发与验证
ACS Omega. 2017 Oct 31;2(10):7120-7126. doi: 10.1021/acsomega.7b00677. Epub 2017 Oct 25.
3
镥-PSMA-1放射化学纯度分析方法的开发与验证
Pharmaceuticals (Basel). 2022 Apr 24;15(5):522. doi: 10.3390/ph15050522.
Comparison of PSMA-HBED and PSMA-I&T as diagnostic agents in prostate carcinoma.
PSMA-HBED 与 PSMA-I&T 在前列腺癌诊断中的比较。
Eur J Nucl Med Mol Imaging. 2017 Aug;44(9):1455-1462. doi: 10.1007/s00259-017-3699-z. Epub 2017 May 4.
4
Comparison of standard and delayed imaging to improve the detection rate of [Ga]PSMA I&T PET/CT in patients with biochemical recurrence or prostate-specific antigen persistence after primary therapy for prostate cancer.比较标准成像和延迟成像以提高[镓]PSMA I&T PET/CT对前列腺癌初次治疗后生化复发或前列腺特异性抗原持续存在患者的检测率。
Eur J Nucl Med Mol Imaging. 2017 Jun;44(6):960-968. doi: 10.1007/s00259-017-3669-5. Epub 2017 Mar 9.
5
Optimization of Labeling PSMA with Ethanol-Postprocessed Ga and Its Quality Control Systems.乙醇后处理镓标记前列腺特异性膜抗原(PSMA)的优化及其质量控制系统
J Nucl Med. 2017 Mar;58(3):432-437. doi: 10.2967/jnumed.116.177634. Epub 2017 Jan 12.
6
Detection rate of PET/CT in patients with biochemical relapse of prostate cancer using [Ga]PSMA I&T and comparison with published data of [Ga]PSMA HBED-CC.使用[镓]PSMA I&T检测前列腺癌生化复发患者中PET/CT的检出率,并与[镓]PSMA HBED-CC的已发表数据进行比较。
Eur J Nucl Med Mol Imaging. 2017 Apr;44(4):670-677. doi: 10.1007/s00259-016-3572-5. Epub 2016 Nov 28.
7
A potential pitfall in the use of Ga-PSMA PET/CT: Anthracosis.镓-前列腺特异性膜抗原正电子发射断层扫描/计算机断层扫描(Ga-PSMA PET/CT)使用中的一个潜在陷阱:煤尘肺。
Rev Esp Med Nucl Imagen Mol. 2017 Jan-Feb;36(1):65-66. doi: 10.1016/j.remn.2016.06.011. Epub 2016 Sep 22.
8
Prostate-Specific Membrane Antigen (PSMA) Avid Pancreatic Neuroendocrine Tumor.前列腺特异性膜抗原(PSMA)高亲和力胰腺神经内分泌肿瘤。
Clin Nucl Med. 2016 Oct;41(10):804-6. doi: 10.1097/RLU.0000000000001308.
9
Gallium-68 DOTATATE Production with Automated PET Radiopharmaceutical Synthesis System: A Three Year Experience.使用自动化PET放射性药物合成系统生产镓-68 DOTATATE:三年经验
Asia Ocean J Nucl Med Biol. 2014 Fall;2(2):75-86.
10
Towards Personalized Treatment of Prostate Cancer: PSMA I&T, a Promising Prostate-Specific Membrane Antigen-Targeted Theranostic Agent.迈向前列腺癌的个性化治疗:PSMA I&T,一种有前景的前列腺特异性膜抗原靶向诊疗试剂。
Theranostics. 2016 Apr 12;6(6):849-61. doi: 10.7150/thno.14744. eCollection 2016.